T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT06343311 · RECRUITING

Trial details

NCT number: NCT06343311
Sponsor: Estrella Biopharma, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-Cell Non-Hodgkin's Lymphoma (NHL)Lymphoma, Non-Hodgkins Lymphomas Non-Hodgkin's B-Cell Non-Hodgkin Lymphoma Non-Hodgkin's Lymphoma Large B-Cell Lymphoma Lymphoma, Non-Hodgkin's, Adult Lymphoma Refractory Non-Hodgkin Lymphoma Relapsed Non-Hodgkin Lymphoma Lymphoma, Non-Hodgkin HIV Associated Lymphoma

Start date: 2024-06-01
Primary completion: 2026-12-31
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.